Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study

dc.contributor.author

Jeewa, Aamir

dc.contributor.author

Chin, Clifford

dc.contributor.author

Pahl, Elfriede

dc.contributor.author

Atz, Andrew M

dc.contributor.author

Carboni, Michael P

dc.contributor.author

Pruitt, Elizabeth

dc.contributor.author

Naftel, David C

dc.contributor.author

Rodriguez, Rose

dc.contributor.author

Dipchand, Anne I

dc.contributor.author

Pediatric Heart Transplant Study (PHTS) Investigators

dc.date.accessioned

2016-03-01T22:46:57Z

dc.date.issued

2015-09-01

dc.description.abstract

© 2015 International Society for Heart and Lung Transplantation.Background Cardiac allograft vasculopathy is an important cause of long-term graft loss. In adults, percutaneous revascularization procedures (PRPs) have variable success with high restenosis rates and little impact on graft survival. Limited data exist in pediatric recipients of transplants. Methods Data from the Pediatric Heart Transplant Study (PHTS) were used to explore associations between PRPs and outcomes after heart transplant in patients listed ≤18 years old who received a first heart transplant between 1993 and 2009. Results Revascularization procedures were done in 28 of 3,156 (0.9%) patients; 13 patients had multiple PRPs giving a total of 51 PRPs performed across 15 centers. Mean recipient age at time of transplant was 7.7 ± 6.7 years; mean donor age was 15.9 ± 15.4 years. The mean time to first PRP was 5.7 ± 3.2 years. Vessels involved were left anterior descending artery (41%), right coronary artery (25%), circumflex artery (18%), other coronary branches/unknown (16%). PRPs consisted of 38 (75%) stent implantations and 13 (25%) balloon angioplasties with an overall procedural success rate of 73%. Freedom from graft loss after PRPs was 89%, 75%, and 61% at 1, 3, and 12 months. In addition, patients with transplants from donors >30 years old were found to have less freedom from the need for a revascularization procedure than patients with transplants from younger donors (p < 0.0001). Conclusions In this large pediatric heart transplant cohort, use of PRPs for cardiac allograft vasculopathy was rare, likely related to procedural feasibility of the interventions. Despite technically successful interventions, graft loss occurred in 39% within 1 year post-procedure; relisting for heart transplant should be considered.

dc.identifier.eissn

1557-3117

dc.identifier.issn

1053-2498

dc.identifier.uri

https://hdl.handle.net/10161/11680

dc.publisher

Elsevier BV

dc.relation.ispartof

Journal of Heart and Lung Transplantation

dc.relation.isversionof

10.1016/j.healun.2014.11.011

dc.title

Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study

dc.type

Journal article

duke.contributor.orcid

Carboni, Michael P|0000-0002-9875-7276

pubs.begin-page

1163

pubs.end-page

1168

pubs.issue

9

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Pediatrics

pubs.organisational-group

Pediatrics, Cardiology

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

pubs.volume

34

Files